Inhaled drug therapy during mechanical ventilation

Clinical Pulmonary Medicine

Volumn 7, Issue 3, 2000, Pages 140-146

  Duarte, Alexander G ^a   Heming, Thomas A ^a   Bidani, Akhil ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Aerosols; Bronchodilators; Inhalation therapy; Mechanical ventilation; Vasodilators

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DORNASE ALFA; HELIUM; IPRATROPIUM BROMIDE; MUCOLYTIC AGENT; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN; SALBUTAMOL; SURFACTANT;

AEROSOL; ARTICLE; ARTIFICIAL VENTILATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; LOWER RESPIRATORY TRACT; NEBULIZER;

EID: 0034081055     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-200007030-00005     Document Type: Article

References (51)

1. Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 1997;156:3-10.
2. Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ. Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med 1999;159:63-8.
3. Dolovich M. Clinical aspects of aerosol physics. Respir Care 1991;9:931-8.
4. Fuller HD, Dolovich MB, Turpie FH, Newhouse MT. Efficiency of bronchodilator aerosol delivery to the lungs from metered-dose inhaler in mechanically ventilated patients: a study comparing four different actuator devices. Chest 1994;105:214-8.
5. Rau JL, Dunlevy CL, Hill RL. A comparison of inline MDI actuators for delivery of a β agonist and a corticosteroid with a mechanically ventilated lung model. Respir Care 1998;43:705-12.
6. Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered-dose inhalers for hand held nebulizers: success and cost savings in a large, acute care hospital. Chest 1992;101:305-8.
7. Hamill RJ, Houston ED, Georghiou PR, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122:762-6.
8. Mancebo J, Amaro P, Lorino H, Lemaire F, Harf A, Brochard L. Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. Am Rev Respir Dis 1991;144:95-100.
9. Manthous CA, Hall JB, Schmidt GA, Wood LDH. Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients. Am Rev Respir Dis 1993;148:1567-70.
10. Dhand R, Duarte AG, Jubran A, et al. Dose response to bronchodilator delivered by meter-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 1996;154:388-93.
11. Wright PE, Carmichael LC, Bernard GR. Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS). Chest 1994;106:1517-23.
12. Navin D, Dhand R, Fink J, Fahey PJ, Tobin MJ. Response to salmeterol delivered by metered-dose inhaler in ventilator-supported patients [abstract]. Am J Respir Crit Care Med 1997:155:A771.
13. Fernandez A, Munoz J, de la Calle B, et al. Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med 1994;20:199-202.
14. Guerin C, Chevre A, Dessirier P, et al. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1036-42.
15. O'Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation. Am Rev Respir Dis 1992;145:1117-22.
16. O'Doherty MJ, Thomas SHL. Nebuliser therapy in the intensive care unit. Thorax 1997; 52(Suppl 2):S56-S59.
17. Fink JB, Varshney R, Goode M, Fahey PJ, Tobin MJ, Dhand R. Does placement of nebulizer before the humidifier improve aerosol delivery during mechanical ventilation? [abstract]. Am J Respir Crit Care Med 1999;159:A86.
18. Harvey CJ, O'Doherty MJ, Page CJ, Thomas SHL, Nunan TO, Treacher DF. Effect of a spacer-on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation. Thorax 1995;50:50-3.
19. Hughes JM, Saez J. Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care 1987;32:1131-5.
20. Spahr-Schopfer IA, Lerman J, Cutz E, Newhouse MT, Dolovich M. Proximate delivery of a large experimental dose from salbutamol MDI induces epithelial airway lesions in intubated rabbits. Am J Respir Crit Care Med 1994;150:790-4.
21. Bihari D, Smithies M, Gimson A, et al. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 1987;317:397-402.
22. Walmrath D, Schneider T, Schermuly R, et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in adult respiratory distress syndrome. Am J Respir Crit Care 1996;153:991-6.
23. Zwissler B, Kemming G, Habler O, et al. Inhaled prostacyclin versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:1671-77.
24. Putensen C, Hormann C, Kleinsasser A, Putesen-Himmer G. Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;157:1743-7.
25. Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W. Effects of aerosolized prostacyclin in severe pneumonia-impact of fibrosis. Am J Respir Crit Care Med 1995; 151:724-30.
26. Lewis JF, Jobe AH. State of the art: surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993;147:218-33.
27. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999;13:1455-76.
28. Spragg RG, Gilliard N, Richman P, et al. Acute effects of a single dose of porcine surfactant on patients with the ARDS. Chest 1994;105:195-202.
29. r et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:1309-15.
30. Lewis JF, Ikegami M, Jobe AH, Tabor B. Aerosolized surfactant treatment of preterm lambs. J Appl Physiol 1991;70:896-76.
31. Anzueto A, Baughman RP, Guntupalli K, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996;334:1417-21.
32. Lutz C, Carney D, Finck C, et al. Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury. Am J Respir Crit Care Med 1998;158:840-5.
33. Schermuly R, Schmehl T, Gunther A, Grimminger F, Seeger W, Walmrath D. Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury: impact on gas exchange. Am J Respir Crit Care Med 1997;156:445-53.
34. Konrad F, Schreiber T, Brecht-Kraus D, Georgieff M. Mucociliary transport in ICU patients. Chest 1994;105:237-41.
35. Zandstra DF, Stoutenbeek CP, Miranda DR. The effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients. Intensive Care Med 1985;11:316-8.
36. Fernandez R, Sole J, Blanch L, Artigas A. The effect of short term instillation of a mucolytic agent (Mesna) on airway resistance in mechanically ventilated patients. Chest 1995;107:1101-6.
37. Voelker KG, Chetty KG, Mahutte CK. Resolution of recurrent atelectasis in spinal cord patients with administration of recombinant human DNase. Intensive Care Med 1996;22:582-4.
38. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340:23-30.
39. Klick JM, duMoulin GC, Hedley-White J, et al. Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. J Clin Invest 1975;55:514-9.
40. Feeley TW, duMoulin GC, Hedley-White J, et al. Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975;293:471-5.
41. Palmer LB, Smaldone GC, Simon SR, O'Riordan TG, Cuccia A. Aerosolized antibiotics in mechanically ventilated patients: delivery and response. Crit Care Med 1998;26: 31-9.
42. Manthous CA, Morgan S, Pohlman A, Hall JB. Heliox in the treatment of airflow obstruction: a critical review of the literature. Respir Care 1997;42:1034-42.
43. Anderson M, Svartengren M, Gunnar B, Philipson K, Camner P. Deposition in asthmatics of particles inhaled in air or helium-oxygen. Am Rev Respir Dis 1993;147:524-8.
44. Henderson SO, Acharya P, Kilaghbian T, Perez J, Korn CS, Chan LS. Use of heliox-driven nebulizer therapy in the treatment of acute asthma. Ann Emerg Med 1999;33:141-6.
45. Gluck EH, Onorato DJ, Castriotta R. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990;98:693-8.
46. Tassaux D, Jolliet P, Thouret J-M, Roeseler J, Dorne R, Chevrolet J-C. Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures. Am J Respir Crit Care Med 1999;160:22-32.
47. Hess DR, Acosta FL, Ritz RH, Kacmarek RM, Camargo CA. The effect of heliox on nebulizer function using a β-agonist bronchodilator. Chest 1999;115:184-9.
48. Habib DM, Garner SS, Brandeburg S. Effect of helium-oxygen on delivery of albuterol in a pediatric, volume cycled, ventilated lung model. Pharmacotherapy 1999;19:143-9.
49. Mizutani T, Layon AJ. Clinical applications of nitric oxide. Chest 1996;110:506-24.
50. Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998;26:15-23.
51. Branson RD, Hess DR, Campbell RS, Johannigman JA. Inhaled nitric oxide: delivery systems and monitoring. Respir Care 1999;44: 281-307.